WASHINGTON, DC: The Academy of HIV Medicine today announced the appointment of Angela C. Riley, PharmD, as their new Manager of Education and Web Programs. A licensed pharmacist, Angela’s clinical background will be instrumental in creating the Academy’s educational content, which extends to all members...
Upcoming Legislative Briefing Also Highlights the Needs of Workforce Expansion Washington, DC: The American Academy of HIV Medicine recognizes the need for greater racial diversity in our healthcare system, including within the HIV workforce. Studies show that racial and ethnic concordance between patients and providers is...
Washington, DC: In response to the Food and Drug Administration's recent approval of Apretude (cabotegravir extended-release injectable suspension) for prevention of HIV and the robust pipeline of additional long-acting antiretroviral agents currently under development, the American Academy of HIV Medicine is pleased to announce it...
Washington, DC: The American Academy of HIV Medicine, the nation’s largest independent HIV care provider organization, today commended the Biden Administration for releasing an updated National HIV/AIDS Strategy (NHAS), which renews the goal of ending the epidemic by 2030. President Biden unveiled the new plan...
Washington, DC: The American Academy of HIV Medicine, the nation’s leading non-profit representing frontline HIV care providers, warns that recent threats to the savings generated by the Federal 340B Drug Pricing Program will compromise access to affordable care, treatment and prevention services for underserved people...
Washington, DC: The American Academy of HIV Medicine today extended its support to the newly introduced bipartisan Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act (H.R. 5602). Sponsored by Reps. Lori Trahan (D-MA) and David McKinley (R-WV), the Act will help to build the next generation of infectious disease experts...